Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells

Multiple Sclerosis Journal

Volumn 21, Issue 5, 2015, Pages 651-655

  Peschl, Patrick ^a   Reindl, Markus ^b   Schanda, Kathrin ^b   Sospedra, Mireia ^b   Martin, Roland ^a   Lutterotti, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

antibody; antigen coupled cell; Multiple sclerosis; myelin; tolerance

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN; MYELIN; ANTINUCLEAR ANTIBODY; MYELIN BASIC PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIGEN COUPLED CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELLS; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; MALE; MIDDLE AGED; TREATMENT DURATION; CLINICAL TRIAL (TOPIC); PATIENT SAFETY;

EID: 84938484385     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514549405     Document Type: Article

References (10)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005 ; 23: 683-747
2. Lutterotti A, Yousef S, Sputtek A, et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: A phase 1 trial in multiple sclerosis. Sci Transl Med. 2013 ; 5 :
3. Di Pauli F, Mader S, Rostasy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011 ; 138: 247-254
4. Pittock SJ, Reindl M, Achenbach S, et al. Anti-myelin antibodies: Frequency, stability and clinicopathologic associations in a biopsy MS cohort. Mult Scler. 2007 ; 13 (1). 7-16
5. Khalil M, Reindl M, Lutterotti A, et al. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. J Neuroimmunol. 2006 ; 174: 147-156
6. Bielekova B, Goodwin B, Richert N, et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand. Nat Med. 2000 ; 6: 1167-1175
7. Turley DM, Miller SD. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J Immunol. 2007 ; 178: 2212-2220
8. Krumbholz M, Derfuss T, Hohlfeld R, et al. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol. 2012 ; 8: 613-623
9. Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008 ; 105: 18889-18894
10. Robinson WH, Fontoura P, Lee BJ, et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol. 2003 ; 21: 1033-1039